Efficacy of Short-Course AZT Plus 3TC to Reduce Nevirapine Resistance in the Prevention of Mother-to-Child HIV Transmission: A Randomized Clinical Trial

por McIntyre, James A., Hopley, Mark, Moodley, Daya, Eklund, Marie, Gray, Glenda E., Hall, David B., Robinson, Patrick, Mayers, Douglas, Martinson, Neil A.
Publicado 2009

Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study

por Baeten, Dominique, Østergaard, Mikkel, Wei, James Cheng-Chung, Sieper, Joachim, Järvinen, Pentti, Tam, Lai-Shan, Salvarani, Carlo, Kim, Tae-Hwan, Solinger, Alan, Datsenko, Yakov, Pamulapati, Chandrasena, Visvanathan, Sudha, Hall, David B, Aslanyan, Stella, Scholl, Paul, Padula, Steven J
Publicado 2018

Nevirapine and Efavirenz Elicit Different Changes in Lipid Profiles in Antiretroviral- Therapy-Naive Patients Infected with HIV-1

por van Leth, Frank, Phanuphak, Prahpan, Stroes, Erik, Gazzard, Brian, Cahn, Pedro, Raffi, François, Wood, Robin, Bloch, Mark, Katlama, Christine, Kastelein, John J. P, Schechter, Mauro, Murphy, Robert L, Horban, Andrzej, Hall, David B, Lange, Joep M. A, Reiss, Peter
Publicado 2004